GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » International Isotopes Inc (OTCPK:INIS) » Definitions » 10-Year RORE %

INIS (International Isotopes) 10-Year RORE % : 0.00% (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is International Isotopes 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. International Isotopes's 10-Year RORE % for the quarter that ended in Sep. 2024 was 0.00%.

The industry rank for International Isotopes's 10-Year RORE % or its related term are showing as below:

INIS's 10-Year RORE % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.095
* Ranked among companies with meaningful 10-Year RORE % only.

International Isotopes 10-Year RORE % Historical Data

The historical data trend for International Isotopes's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Isotopes 10-Year RORE % Chart

International Isotopes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.32 -54.39 -23.68 - -10.00

International Isotopes Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.92 -10.00 -5.26 -11.11 -

Competitive Comparison of International Isotopes's 10-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, International Isotopes's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Isotopes's 10-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, International Isotopes's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where International Isotopes's 10-Year RORE % falls into.



International Isotopes 10-Year RORE % Calculation

International Isotopes's 10-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( -0.017-0 )
=/-0.017
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 10-year before.


International Isotopes  (OTCPK:INIS) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


International Isotopes 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of International Isotopes's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


International Isotopes Business Description

Traded in Other Exchanges
N/A
Address
4137 Commerce Circle, Idaho Falls, ID, USA, 83401
International Isotopes Inc manufactures a full range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and other sealed sources. International Isotopes also distributes a varied selection of radioisotopes and radiochemicals for medical and clinical research, and pharmacy compounding. International Isotopes's business consists of four business segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. Geographically, it generates the majority of its revenue from the United States.
Executives
W Matthew Cox officer: Chief Financial Officer C/O INTERNATIONAL ISOTOPES INC., 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Shahe Bagerdjian officer: President 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Christopher G Grosso director, 10 percent owner C/O KERSHNER GROSSO & CO, 480 BROADWAY, SARASOTA SPRINGS NY 12866
Robert Atcher director 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Laurie Mckenzie-carter officer: Chief Financial Officer 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Steve Laflin director, officer: Pres. & CEO 1258 E AIRPORT ROAD, BLACKFOOT ID 83221
William W Nicholson 10 percent owner 121 NORTH POST OAK LANE STE 2105, HOUSTON TX 77024
Ralph M Richard director, 10 percent owner 350 SHORE DRIVE, OAKDALE NY 11769
John M Mccormack 10 percent owner 4137 COMMERCE CIRCLE, IDAHO FALLS ID 83401
Walter D Ohearn other: Part of 13D group 1115 5TH AVENUE, NEW YORK NY 10128
Keane Marie C & Keane James Jtwros 10 percent owner